Acute hepatitis C: prevention and treatment

  title={Acute hepatitis C: prevention and treatment},
  author={Resat Ozaras and Veysel Tahan},
  journal={Expert Review of Anti-infective Therapy},
  pages={351 - 361}
  • R. Ozaras, V. Tahan
  • Published 1 April 2009
  • Medicine, Biology
  • Expert Review of Anti-infective Therapy
HCV can cause acute or chronic hepatitis and is a health problem all over the world. It is one of the leading causes of cirrhosis and hepatocellular carcinoma, and is a common indication for liver transplantation. Unrecognized patients with HCV infection may transmit the virus to uninfected people. The acute form of the disease leads to chronic hepatitis in the majority of cases. Since the success rate of treatment given in the chronic phase is much lower than that given in the acute phase… 

Management of Chronic Hepatitis C Virus Infection: Current Perspectives

H hepatitis C virus infection leads to hepatic inflammation, steatosis, cirrhosis, and greater risk of hepatocellular carcinoma, and clinical manifestations include acute infection, chronic infection, non-hepatic complications, and occult infection.

Feasibility of Hepatitis C Elimination in China: From Epidemiology, Natural History, and Intervention Perspectives

Identifying secondary HCV infections, especially in HCV patients co-infected with the human immunodeficiency virus (HIV) is a priority and enhancing universal access to direct antiviral agents (DAAs) treatment regimens is an effective way to improve the cure rate of HCV infection.

Occult Hepatitis C Infection Should Be More Noticed With New Treatment Strategies

A condition that CHC cannot be diagnosed with the mentioned routine diagnostic tests is thought about and Imagine about dimensions of this condition on the health status of society.

Early interferon-based treatment after detection of persistent hepatitis C virus infection: a critical decision.

The cost-benefit analysis seems to indicate that in patients who are motivated and without contraindications, starting the treatment as early as possible is probably the best choice for success, and indeed, the final decision for starting treatment should be a case-by-case point.

Hepatitis B, C, and Delta—Updates in Screening and Infection Prevention Opportunities for Eradication

Although these drugs will not lead to the eradication of hepatitis C, they will significantly decrease the burden of this disease, avoiding the evolution for severe clinical pictures, such as liver cirrhosis, liver failure, and hepatocellular carcinoma.

An overview on hepatitis C virus genotypes and its control

Hepatitis B and C are global health care problems months is very low . causing morbidity and mortality worldwide and spreading like an epidemic in developing countries like Cirrhosis along with its complications like

  • Medicine, Biology
  • 2013
There is close association in the development of type 2 diabetes mellitus in patients with chronic hepatitis C, and there is growing evidence to support the concept that HCV infection is a risk factor for developing type 2 Diabetes Mellitus.

Comparison of hepatitis C virus risk factors in genotypes 1a and 3a

Background: One of the most important causes of chronic liver disease is hepatitis C virus (HCV), which causes liver cirrhosis and hepatocellular carcinoma. To control the prevalence of the disease,

New Perspective in HCV Clinical and Economical Management of the Current and Future Therapies

Even though new medications for hepatitis C are effective disease modifiers and have the potential, in a long term perspective, to eradicate the pathology, the cost of new treatments are unlikely to be sustainable for the NHSs.

Assessing possible Different routes of HCV transmission

This work aimed to detect possible other routes of HCV transmission using ELISA and western blotting techniques because body fluids other than blood might be potential sources ofHCV infection.



Acute hepatitis C virus infection: A chronic problem

The current information regarding the understanding of the epidemiology, virology, and immunology of HCV with a particular emphasis on acute HCV infection is reviewed and an algorithm for the diagnosis and management of acute HCv infection is proposed.

Acute Hepatitis C: A Systematic Review

  • S. Kamal
  • Medicine
    The American Journal of Gastroenterology
  • 2008
An improvement in the ability to diagnose and treat patients with acute hepatitis C would have a significant impact on the prevalence of chronic hepatitis and its associated complications particularly in countries with a high endemic background of the infection.

Hepatitis C: the clinical spectrum of the disease.

Epidemiology of hepatitis C virus infection.

  • R. Esteban
  • Medicine, Biology
    Journal of hepatology
  • 1993

Natural history of acute HCV infection in hemodialysis patients.

The aim of this study was to analyze the evolution towards chronic hepatopathy in 19 cases of acute hepatitis C observed in hemodialysis patients from 1990 to 2001, and it is important to stress that HCV infection spontaneously cleared in 4 out of 19 patients (21%).

Treatment of acute hepatitis C with interferon alfa-2b.

Treatment of acute hepatitis C with interferon alfa-2b with treatment during the acute phase could prevent the development of chronic infection.

Risk factors and outcome among a large patient cohort with community-acquired acute hepatitis C in Italy.

These findings underscore the importance of medical procedures as risk factors in the current spread of HCV infection in Italy and show that none of the variables considered (including asymptomatic disease) were associated with increased risk of developing chronic hepatitis C.

Acute hepatitis C virus infection assessment among chronic hemodialysis patients in the Southwest Parana State, Brazil

Laboratory tests results showed variable ALT preceding anti-HCV seroconversion and intermittent viremia, which contributed importantly to restrain the appearance of new cases of acute hepatitis C in this center and the last case was diagnosed in May 2004.